Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Dovato, which combines the integrase strand transfer inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine, was approved to treat HIV-1 infection in adolescents 12 years and older, making it the first oral, two-drug, single-tablet regimen available for this patient population, according to ViiV
Relative mRNA expression was calculated by Ct method
Glenys, UK It was extremely interesting reading through some of the reviews on here
Muller C, et al
US$ 21.07
US$ 28.96
US$ 25.83
US$ 26.36
US$ 24.36
US$ 21.63
US$ 26.81
